- Home
- KURA vs FLOC Comparison
KURA vs FLOC Comparison
Compare KURA & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KURA | FLOC |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | 1281 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 841.6M | 949.8M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | FLOC |
|---|---|---|
| Price | $10.40 | $19.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $25.56 | ★ $28.50 |
| AVG Volume (30 Days) | ★ 1.4M | 549.5K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | $22.92 |
| Revenue Next Year | $106.37 | $8.59 |
| P/E Ratio | ★ N/A | $16.57 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.45 | $14.03 |
| 52 Week High | $12.49 | $28.26 |
Technical Indicators
Market Signals| Indicator | KURA | FLOC |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 34.57 |
| Support Level | $8.53 | $17.46 |
| Resistance Level | $10.97 | $24.58 |
| Average True Range (ATR) | 0.47 | 0.83 |
| MACD | -0.17 | 0.07 |
| Stochastic Oscillator | 10.29 | 2.58 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About FLOC Flowco Holdings Inc.
Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.